These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308 [TBL] [Abstract][Full Text] [Related]
23. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079 [TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation. Duan W; Zhang L Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538 [TBL] [Abstract][Full Text] [Related]
25. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro]. Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553 [TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235 [TBL] [Abstract][Full Text] [Related]
27. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526 [TBL] [Abstract][Full Text] [Related]
28. Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. Johnson KP; Rowe GC; Jackson BA; D'Agustino JL; Campbell PE; Guillory BO; Williams MV; Matthews QL; McKay J; Charles GM; Verret CR; Deleon M; Johnson DE; Cooke DB Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1039-45. PubMed ID: 11785654 [TBL] [Abstract][Full Text] [Related]
29. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
30. Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines. Witters LM; Crispino J; Fraterrigo T; Green J; Lipton A Am J Clin Oncol; 2003 Aug; 26(4):S92-7. PubMed ID: 12902864 [TBL] [Abstract][Full Text] [Related]
31. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants. Fu YG; Sung JJ; Wu KC; Wu HP; Yu J; Chan M; Chan VY; Chan KK; Fan DM; Leung WK Cancer Lett; 2005 Jun; 224(2):243-52. PubMed ID: 15914275 [TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines. Kamijo T; Sato T; Nagatomi Y; Kitamura T Int J Urol; 2001 Jul; 8(7):S35-9. PubMed ID: 11442675 [TBL] [Abstract][Full Text] [Related]
34. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633 [TBL] [Abstract][Full Text] [Related]
35. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955 [TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms. Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579 [TBL] [Abstract][Full Text] [Related]
37. [Molecular mechanism of cyclooxygenase-2 inhibitor in inhibition of proliferation of colon cancer cells by modulating Stat5 signal transduction pathway]. Ma XT; Yu LW; Wang S; Zhang H; Du RY; Cui ZR Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2566-9. PubMed ID: 16321305 [TBL] [Abstract][Full Text] [Related]
38. Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro. McFadden DW; Riggs DR; Jackson BJ; Cunningham C Int J Oncol; 2006 Oct; 29(4):1019-23. PubMed ID: 16964399 [TBL] [Abstract][Full Text] [Related]
40. MCF-7 breast cancer cell line grown in agarose culture for study of COX-2 inhibitors in three-dimensional growth system. Kinder DH; Aulthouse AL Cancer Lett; 2004 Mar; 205(1):49-53. PubMed ID: 15036660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]